Data, Data Everywhere
Executive Summary
As heaps of genetic and chemical data pile up in research databases, Molecular Applications Group is trying to build a business in bioinformatics. But the industry is so new, neither the goals nor the rules are clear. Pricing, service, and standardization are key issues as MAG and its competitors look for business models that not only work today, but can evolve as well.
You may also be interested in...
Industry Pushes For Revised PFAS Definition In California Bill Seeking Cosmetic Ban
The Personal Care Products Council and other industry groups suggest they will support AB 2771 if amendments are made to promote international harmonization, among other changes. Already they advocated successfully for the bill’s scope to be limited to intentionally added PFAS, not “the mere presence of trace levels of fluorine in the product.”
Senate’s US FDA User Fee Bill Answers Biosimilar Interchangeable Exclusivity Questions
The bill would allow for tentative interchangeable approvals, as well as shared first interchangeable exclusivity for multiple first filers.
Hemp Roundtable Says Safety Study Data Should Convince Congress On Lawful CBD Use
Study of 1,061 subjects showed oral CBD has robust safety profile, addressing FDA’s safety concerns and providing evidence to convince agency to take action on CBD regulation, say trade groups.